Literature DB >> 9512534

Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.

M P Sowden1, M J Eagleton, H C Smith.   

Abstract

Apolipoprotein B (apoB) RNA editing involves a cytidine to uridine transition at nucleotide 6666 (C6666) 5' of an essential cis -acting 11 nucleotide motif known as the mooring sequence. APOBEC-1 (apoB editing catalytic sub-unit 1) serves as the site-specific cytidine deaminase in the context of a multiprotein assembly, the editosome. Experimental over-expression of APOBEC-1 resulted in an increased proportion of apoB mRNAs edited at C6666, as well as editing of sites that would otherwise not be recognized (promiscuous editing). In the rat hepatoma McArdle cell line, these sites occurred predominantly 5' of the mooring sequence on either rat or human apoB mRNA expressed from transfected cDNA. In comparison, over-expression of APOBEC-1 in HepG2 (HepG2-APOBEC) human hepatoma cells, induced promiscuous editing primarily 5' of the mooring sequence, but sites 3' of the C6666 were also used more efficiently. The capacity for promiscuous editing was common to rat, rabbit and human sources of APOBEC-1. The data suggested that differences in the distribution of promiscuous editing sites and in the efficiency of their utilization may reflect cell-type-specific differences in auxiliary proteins. Deletion of the mooring sequence abolished editing at the wild type site and markedly reduced, but did not eliminate, promiscuous editing. In contrast, deletion of a pair of tandem UGAU motifs 3' of the mooring sequence in human apoB mRNA selectively reduced promiscuous editing, leaving the efficiency of editing at the wild type site essentially unaffected. ApoB RNA constructs and naturally occurring mRNAs such as NAT-1 (novel APOBEC-1 target-1) that lack this downstream element were not promiscuously edited in McArdle or HepG2 cells. These findings underscore the importance of RNA sequences and the cellular context of auxiliary factors in regulating editing site utilization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512534      PMCID: PMC147457          DOI: 10.1093/nar/26.7.1644

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins.

Authors:  J Greeve; I Altkemper; J H Dieterich; H Greten; E Windler
Journal:  J Lipid Res       Date:  1993-08       Impact factor: 5.922

2.  Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein.

Authors:  C Hadjiagapiou; F Giannoni; T Funahashi; S F Skarosi; N O Davidson
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

3.  Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.

Authors:  S G Harris; I Sabio; E Mayer; M F Steinberg; J W Backus; J D Sparks; C E Sparks; H C Smith
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

4.  Apolipoprotein B mRNA sequences 3' of the editing site are necessary and sufficient for editing and editosome assembly.

Authors:  J W Backus; H C Smith
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

5.  Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro.

Authors:  J W Backus; H C Smith
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

6.  Specific 3' sequences flanking a minimal apolipoprotein B (apoB) mRNA editing 'cassette' are critical for efficient editing in vitro.

Authors:  J W Backus; H C Smith
Journal:  Biochim Biophys Acta       Date:  1994-01-18

7.  Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48.

Authors:  F Giannoni; D K Bonen; T Funahashi; C Hadjiagapiou; C F Burant; N O Davidson
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

Review 8.  Apolipoprotein B mRNA editing: the sequence to the event.

Authors:  H C Smith
Journal:  Semin Cell Biol       Date:  1993-08

9.  Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA.

Authors:  D M Driscoll; S Lakhe-Reddy; L M Oleksa; D Martinez
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

View more
  11 in total

Review 1.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

2.  Hypermutation induced by APOBEC-1 overexpression can be eliminated.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Gyorgy Csako; Amy P Patterson
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

3.  Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U Editing.

Authors:  Philipp Schaefermeier; Sarah Heinze
Journal:  Mol Syndromol       Date:  2016-12-16

4.  Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.

Authors:  Valerie Blanc; Yan Xie; Jianyang Luo; Susan Kennedy; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2012-09-19       Impact factor: 5.922

5.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Authors:  Martin Hersberger; Susannah Patarroyo-White; Xiaobing Qian; Kay S Arnold; Lucia Rohrer; Maureen E Balestra; Thomas L Innerarity
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

6.  Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle RH-7777 cells by expression of betaine-homocysteine S-methyltransferase.

Authors:  M P Sowden; H L Collins; H C Smith; T A Garrow; J D Sparks; C E Sparks
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

7.  Commitment of apolipoprotein B RNA to the splicing pathway regulates cytidine-to-uridine editing-site utilization.

Authors:  M P Sowden; H C Smith
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

8.  APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.

Authors:  G S Dance; M P Sowden; Y Yang; H C Smith
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

9.  The expression of apoB mRNA editing factors is not the sole determinant for the induction of editing in differentiating Caco-2 cells.

Authors:  Chad A Galloway; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2009-11-20       Impact factor: 3.575

10.  APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.

Authors:  Saeed Soleymanjahi; Valerie Blanc; Nicholas Davidson
Journal:  RNA       Date:  2021-06-03       Impact factor: 5.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.